• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,193.07 390.17
( 0.51%)
Global Indices
Nasdaq
51,585.70 72.15
(0.14%)
Dow Jones
7,521.58 80.48
(1.08%)
Hang Seng
72,454.13 1,204.07
(1.69%)
Nikkei 225
10,357.71 -41.99
(-0.40%)
Forex
USD-INR
94.39 -0.12
(-0.13%)
EUR-INR
108.40 -1.03
(-0.94%)
GBP-INR
125.08 -1.43
(-1.13%)
JPY-INR
0.59 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Mantra Capital Limited
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
511577
INE304E01010
9.5653943
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
59.04
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Wanbury explores new market opportunities for its new APIs
Jun 10,2026

Wanbury announced the company has expanded regulatory submission for launch of new Active Pharmaceuticals Ingredients (APIs).

For Diphenhydramine HCl, company submitted DMF to Malaysia and Singapore.

The Company proposed to explore new market opportunities for Paroxetine HCl in Korea and Latin America by submitting the DMFs.

Company also received formal audit report from MFDS (Korea FDA) for its Patalganga facility stating zero observation for the inspection conducted in April 2026.